Skip to main content

and
  1. No Access

    Article

    Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome

    The HSD11B1 gene encodes the type 1 isoform of the 11-β-hydroxysteroid dehydrogenase that is responsible for the regeneration of glucocorticoids from hormonally-inactive metabolites into active forms in a tissue-...

    Vince Kornél Grolmusz, Orsolya Dóra Ács in Molecular Biology Reports (2014)

  2. Article

    Open Access

    Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression

    Previously, drug-based synchronization procedures were used for characterizing the cell cycle dependent transcriptional program. However, these synchronization methods result in growth imbalance and alteration...

    Vince Kornél Grolmusz, Eszter Angéla Tóth, Kornélia Baghy, István Likó in BMC Genomics (2016)

  3. No Access

    Article

    MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism

    Inherited, germline mutations of menin-coding MEN1 gene cause multiple endocrine neoplasia type 1 (MEN1), while somatic MEN1 mutations are the sole main driver mutations in sporadic primary hyperparathyroidism (P...

    Vince Kornél Grolmusz, Katalin Borka, Annamária Kövesdi, Kinga Németh in Virchows Archiv (2017)

  4. Article

    Open Access

    True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome

    Multiple endocrine neoplasia type 1 is a rare tumor syndrome caused by germline mutations of MEN1 gene. Phenotype varies widely, and no definitive correlation with the genotype has been observed. Mutation-negativ...

    Annamária Kövesdi, Miklós Tóth, Henriett Butz, Nikolette Szücs, Beatrix Sármán in Endocrine (2019)

  5. Article

    Open Access

    Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model

    CDK4/6 inhibitors such as ribociclib are becoming widely used targeted therapies in hormone-receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2−) breast cancer. However, cancers can...

    Vince Kornél Grolmusz, **feng Chen, Rena Emond in Cancer Cell International (2020)

  6. Article

    Open Access

    Cell facilitation promotes growth and survival under drug pressure in breast cancer

    The interplay of positive and negative interactions between drug-sensitive and resistant cells influences the effectiveness of treatment in heterogeneous cancer cell populations. Here, we study interactions be...

    Rena Emond, Jason I. Griffiths, Vince Kornél Grolmusz, Aritro Nath in Nature Communications (2023)